NKCFO LLC’s CVS Health CVS Stock Holding History

NKCFO LLC’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,000	Closed	-$137K	–	127
2020 Q4	$137K	Hold	2,000	–	–	0.05%	78
2020 Q3	$117K	Buy	+2,000	New	+$124K	0.05%	77

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NKCFO LLC's CVS Position: Q1 2021 in Review

NKCFO LLC sold out of CVS Health (CVS) in Q1 2021, closing a stake of 2,000 shares — an estimated $137K sold.

NKCFO LLC first reported a position in CVS in Q3 2020 and held it in 2 quarters. The position peaked at $137K in Q4 2020. 2,032 funds tracked by Wall St. Rank hold CVS as of Q1 2021.

NKCFO LLC reported no remaining CVS Health position as of Q1 2021 after selling out during the quarter.
NKCFO LLC sold 2,000 CVS Health shares in Q1 2021, an estimated $137K.
NKCFO LLC first reported a position in CVS Health in Q3 2020 and held it in 2 quarters.
NKCFO LLC's CVS Health position peaked at $137K in Q4 2020.
2,032 funds tracked by Wall St. Rank held CVS Health as of Q1 2021.

Based on NKCFO LLC's 13F filing for Q1 2021, filed 3 May 2021.